Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. ProANP and proBNP in plasma as biomarkers of heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Commentary: Measurement of biomarkers in medicine

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Copeptin levels and invasive hemodynamics in patients with advanced heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Fetal cells in maternal blood for prenatal diagnosis: A love story rekindled

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Chromogranin A in the mammalian heart: expression without secretion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Strategies to improve patient-reported outcome completion rates in longitudinal studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. N-terminal pro-C-type natriuretic peptide in serum associated with bone destruction in patients with multiple myeloma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Marita Westhrin
  • Siv Helen Moen
  • Ida Bruun Kristensen
  • Glenn Buene
  • Anne Kærsgaard Mylin
  • Ingemar Turesson
  • Niels Abildgaard
  • Anders Waage
  • Therese Standal
Vis graf over relationer

Chemerin is a recently discovered adipokine shown to be involved in both inflammatory and metabolic processes. Here, we demonstrate that chemerin serum levels are elevated in patients with multiple myeloma and that it increases with disease progression. We found that chemerin is expressed by stromal cells and preadipocytes, whereas its receptor CCRL2 is expressed by primary myeloma cells, suggesting a paracrine signaling loop between bone marrow stromal cells/adipocytes and myeloma cells. This is the first study exploring chemerin and its receptors in multiple myeloma.

OriginalsprogEngelsk
TidsskriftBiomarker Research
Vol/bind6
Udgave nummer21
Sider (fra-til)4
ISSN2050-7771
DOI
StatusUdgivet - 2018

ID: 56670289